MSD meeting - Utilizing Immunotherapy in Urologic Practice

AGENDA

17:30-18:00 Gathering + Opening
18:00-19:00 Molecular Fundamentals and Rationale for Immunotherapy in Solid Tumors Prof. Gal Markel, Director of Davidoff & Deputy Director General, Rabin Medical Center
19:00-20:00 Best Practice in Patient Management in I-O Era Dr. Ronnie Shapira, Chief Physician of the Ella Institute for Immuno-Oncology Center and Research of Melanoma and Skin Cancer at Sheba Medical Center
20:00-20:15 Break
20:15-21:00 The Importance of Multidisciplinary Treatment in Immunotherapy - The Nurse Perspective Yael Steinberg, Head Nurse of the Ella Institute for Immuno-Oncology Center Melanoma Treatment Center, Sheba Medical Center

17:30-18:00 Gathering
18:00-19:00 The Rational and Evolvement of Systemic Therapy in Early Bladder Cancer Dr. Andrea Necchi, Associate Prof. Head of Genitourinary Medical Oncology San Raffaele, Milano, Italy
19:00-19:30 Treatment Paradigm in NMIBC Prof. Amiel Gilad, Director Department of Urology, Rambam Health Care Campus, Israel
19:30-20:00 The Evolvement of Immunotherapy in Advance Urothelial Cancer Dr. Avivit Peer, Head of Clinical Trials Unit, Head of Genitourinary clinic, Oncology Institute, Rambam Health Care Campus. Haifa, Israel
20:00-20:15 Break
20:15-21:00 Workshop - Cases Discussions in Groups Lead by Urologists and Oncologists

17:30-18:00 Gathering
18:00-19:00 Immunotherapy in NMIBC – Clinical Aspects and Practical Management Dr. Arjun Vasant Balar, Associate Professor of Medicine Director – Genitourinary Medical Oncology Program, Medical Director – Clinical Trials Office Laura and Isaac Perlmutter Cancer Center An NCI-Designated Comprehensive Cancer Center
19:00-19:45 Workshop - Cases Discussions in Groups Lead by Urologists and Oncologists
19:45-20:00 Break
20:00-20:30 Discussion and Proposals for Treatment Protocols for Optimal Management in the Hospitals Lead by Urologists
20:30-21:00 Urologists Discussion - Next Steps in Data and Research IUOC Group